Select your preferred language.

Choisissez votre langue préférée

Tuesday, March 14, 2017

Bayer launches Trilex EverGol SHIELD, designed to maximize ease of use

Trilex EverGol SHIELD

Guelph, ON (March 14, 2017) – Bayer has announced the launch of Trilex® EverGol® SHIELD fungicide and insecticide seed treatment, in a convenient package that offers complete disease and insect protection against the expanding presence of pea leaf weevil and wireworms for pulse growers in Western Canada.

Trilex EverGol SHIELD is ideal for on-farm treating or for smaller batches towards the end of the treating season, and combines penflufen (Group 7), trifloxystrobin (Group 11) and metalaxyl (Group 4) with Stress Shield® insecticide seed treatment (Group 4) that together provide exceptional seed- and soil-borne disease protection against rhizoctonia, ascochyta, pythium, fusarium and botrytis.

“The launch of Trilex EverGol SHIELD in Canada offers a powerful tool for Canadian pulse growers against the growing threat of pea leaf weevil and wireworm, and puts the control in the applicator’s or grower’s hands” says David Kikkert, Crop & Campaign Marketing Manager, Soybeans & Pulses at Bayer. “This new tri-pak is offered in response to the expanding presence of these diseases and insects in Western Canada.”

Trilex EverGol SHIELD offers exceptional germination when compared to untreated seed, helping to promote a high-performing root system that supports optimal access to water and nutrients in the development phase. The result is a positive impact on plant stand and establishment, leading to healthier plant development, faster growth and higher yields.

“Most economic losses result from larva feeding on rhizobium or nitrogen-fixing nodules located on plant roots in field peas and faba beans,” says Kikkert. “The addition of Stress Shield to control pea leaf weevil and wireworm will offer Canadian pulse growers peace of mind and improve both yield and quality of their crop.”

Trilex EverGol SHIELD is a concentrated formulation; growers have the flexibility to decrease water volume when adding Stress Shield, micronutrients and/or inoculants. This extra control allows for an optimized application volume and uniform coverage, which helps prevent product overload, allows for low seed moisture content and makes for easier flow through equipment.

For more information regarding Trilex EverGol SHIELD, growers are encouraged to talk to their local retailer or visit

Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2016, the Group employed around 115,200 people and had sales of EUR 46.8 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.7 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to

For further information, contact:

David Kikkert
Crop & Campaign Marketing Manager, Soybeans and Pulse
Bayer CropScience Inc.
Phone: 519-767-3888

Lauren Davis
Marketing Communications Manager
Bayer CropScience Inc.
Phone: 403-723-7450

Jackie Elliott
Account Director
Weber Shandwick Canada
Phone: 416-642-7899

Forward-Looking Statements

This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.